A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/26 (2006.01) C07K 14/605 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2263802
This invention provides a method of attenuating post-surgical catabolic changes and hormonal responses to stress. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
Cette invention se rapporte à un procédé d'atténuation des modifications cataboliques postopératoires et des réactions hormonales au stress. Conformément à ce procédé, on administre du GLP-1, un analogue de GLP-1 ou un dérivé de GLP-1, en quantité suffisante pour régulariser le glucose sanguin.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Use of glucagon-like peptide-1 (glp-1) or analogs to abolish... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of glucagon-like peptide-1 (glp-1) or analogs to abolish..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glucagon-like peptide-1 (glp-1) or analogs to abolish... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1654514